1,560 reports of this reaction
6.2% of all DIROXIMEL FUMARATE reports
#1 most reported adverse reaction
FLUSHING is the #1 most commonly reported adverse reaction for DIROXIMEL FUMARATE, manufactured by Biogen Inc.. There are 1,560 FDA adverse event reports linking DIROXIMEL FUMARATE to FLUSHING. This represents approximately 6.2% of all 25,327 adverse event reports for this drug.
Patients taking DIROXIMEL FUMARATE who experience flushing should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FLUSHING is moderately reported among DIROXIMEL FUMARATE users, representing a notable but not dominant share of adverse events.
In addition to flushing, the following adverse reactions have been reported for DIROXIMEL FUMARATE:
The following drugs have also been linked to flushing in FDA adverse event reports:
FLUSHING has been reported as an adverse event in 1,560 FDA reports for DIROXIMEL FUMARATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
FLUSHING accounts for approximately 6.2% of all adverse event reports for DIROXIMEL FUMARATE, making it one of the most commonly reported side effect.
If you experience flushing while taking DIROXIMEL FUMARATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.